ECONOMIC IMPLICATIONS OF BUDESONIDE MMX® ADVANTAGE IN ULCERATIVE COLITIS TREATMENT OVER SYSTEMIC STEROIDS- BUDESONIDE MMX® DECREASES ULCERATIVE COLITIS TREATMENT COSTS
Abstract
Authors
A. Bierut M. Jesionowski C. Pruszko M. Jachimowicz M. Kowalczyk P. Książek